Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis

Introduction: The CFTR modulator drug elexacaftor/tezacaftor/ivacaftor (ETI) was shown to improve CFTR function and clinical symptoms in patients with cystic fibrosis (CF) with at least one F508del allele. Recently, some case reports suggested potential side effects of ETI on mental health with an i...

Full description

Saved in:
Bibliographic Details
Main Authors: Linus Piehler (Author), Ralf Thalemann (Author), Christine Lehmann (Author), Stephanie Thee (Author), Jobst Röhmel (Author), Zulfiya Syunyaeva (Author), Mirjam Stahl (Author), Marcus A. Mall (Author), Simon Y. Graeber (Author)
Format: Book
Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available